GAS5 and non-small cell lung carcinoma: Likewise, GAS5 levels in plasma are found to be decreased in diabetes type 2 patients and are even further decreased in CAD patients [114], but GAS5 levels in plasma are also decreased in non-small cell lung cancer patients [115].